Related Experiment Video
Updated: Jun 22, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Telemedicine and home spirometry in cystic fibrosis: A prospective multicenter study
Jakob Medbo1,2, Henrik Imberg3, Christine Hansen4
1Department of Pediatrics, Institute of Clinical Science at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Insights
Telehealth and home spirometry in cystic fibrosis (CF) care showed no negative impact on disease progression. This approach offers flexibility and personalization, with high patient and caregiver satisfaction.
Area of Science:
- Pediatric Pulmonology
- Digital Health
- Chronic Disease Management
Background:
- Feasibility of telehealth and home spirometry for pediatric cystic fibrosis (CF) patients is established.
- Impact of these technologies on CF disease progression requires assessment.
Purpose of the Study:
- Evaluate the effects of integrating telehealth and home spirometry into CF care.
- Assess the impact on disease progression and overall patient care.
Main Methods:
- Children with CF (5-17 years) used home spirometers, replacing some in-person visits with telemedicine.
- Compared disease progression trajectories (FEV1%, lung clearance index, BMI) using linear mixed-effects models.
- Collected data on airway pathogens, sputum cultures, antibiotic use, and patient/caregiver stress levels.
Main Results:
- No significant differences in FEV1%, lung clearance index, or BMI progression rates were observed between telehealth/home spirometry and pre-pandemic in-person care.
- No significant changes in airway pathogen incidence, sputum cultures, or antibiotic use.
- The intervention did not increase patient or caregiver stress; high satisfaction reported.
Conclusions:
- Combining telehealth and home spirometry with in-person visits provides comparable effectiveness to traditional care.
- This integrated approach enhances flexibility and personalization in managing pediatric cystic fibrosis.
- High patient and caregiver preference for continuing telehealth and home spirometry services.
Objectives:
Telehealth and home spirometry feasibility for children has been established, but their impact on cystic fibrosis (CF) disease progression remains unassessed. We aimed to evaluate the effects of telehealth and home spirometry on CF disease progression and care.
Methods:
Children with CF aged 5-17 years from all Swedish CF centers were provided with home spirometers. A minimum of two in-person visits were replaced with telemedicine visits and participants were instructed to conduct home spirometry before visits. Linear mixed-effects models were used to compare annual CF disease trajectories during the intervention period and prepandemic period (1 January 2019 to 28 February 2020). Participants and caregivers completed study questionnaires.
Results:
A total of 59 individuals completed the study over a mean (SD) period of 6.8 (1.4) months, made 3.1 (1.0) physical visits and 2.2 (0.6) telehealth visits per patient year during the study period. The mean difference (95% CI) between the intervention and prepandemic period progression rate for FEV1%, lung clearance index and BMI were -0.4 (-1.3 to 0.5, p = 0.39), 0.11 (-0.07 to 0.28, p = 0.25) and -0.02 (-0.13 to 0.08, p = 0.70), respectively. There were no major shifts in the incidence of airway pathogens, sputum cultures, or antibiotics use between the periods (p > 0.05). The intervention did not increase stress. Almost all participants and caregivers expressed a desire to continue with home spirometry and telemedicine.
Conclusion:
Combining telehealth and physical visits with access to home spirometry demonstrated comparable effectiveness as exclusively in-person care with enhanced flexibility and personalization of CF care.
More Related Videos
07:38Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chest Physiotherapy
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Chronic Obstructive Pulmonary Disease-I: Introduction